Chitosan, derivatives, and its nanoparticles: Preparation, physicochemical properties, biological activities, and biomedical applications – A comprehensive review DOI
Mohamed T. El‐Saadony, Ahmed M. Saad, Samar Sami Alkafaas

et al.

International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 142832 - 142832

Published: April 1, 2025

Language: Английский

Phyllanthus emblica Fruit Improves Obesity by Reducing Appetite and Enhancing Mucosal Homeostasis via the Gut Microbiota–Brain–Liver Axis in HFD-Induced Leptin-Resistant Rats DOI Creative Commons

Hsin‐Yu Chang,

Sheng-Yi Chen, Jer‐An Lin

et al.

Journal of Agricultural and Food Chemistry, Journal Year: 2024, Volume and Issue: 72(18), P. 10406 - 10419

Published: April 25, 2024

The impact of leptin resistance on intestinal mucosal barrier integrity, appetite regulation, and hepatic lipid metabolism through the microbiota–gut–brain–liver axis has yet to be determined. Water extract Phyllanthus emblica L. fruit (WEPE) its bioactive compound gallic acid (GA) effectively alleviated methylglyoxal (MG)-triggered in vitro. Therefore, this study investigated how WEPE GA intervention relieve resistance-associated dysfunction mucosa, appetite, accumulation high-fat diet (HFD)-fed rats. results showed that significantly reduced tissues (jejunum, brain, liver) MG-evoked resistance, malondialdehyde (MDA), proinflammatory cytokines, SOCS3, orexigenic neuropeptides, increasing receptor, tight junction proteins, antimicrobial peptides, anorexigenic excretion fecal triglyceride (TG), short-chain fatty acids (SCFAs) via a positive correlation with Allobaculum Bifidobacterium microbiota. These novel findings suggest holds potential as functional food ingredient for alleviating obesity complications.

Language: Английский

Citations

4

The role of gut microbiota in anorexia induced by T-2 toxin DOI Creative Commons

Tingyu Huang,

Aoyun Li,

Shanshan Zhang

et al.

Ecotoxicology and Environmental Safety, Journal Year: 2024, Volume and Issue: 281, P. 116612 - 116612

Published: June 18, 2024

T-2 toxin is one of trichothecene mycotoxins, which can impair appetite and decrease food intake. However, the specific mechanisms for toxin-induced anorexia are not fully clarified. Multiple research results had shown that gut microbiota have a significant effect on regulation. Hence, this study purposed to explore potential interactions regulate factors in induced by toxin. The divided mice into control group (CG, 0 mg/kg BW toxin) toxin-treated (TG, 1 toxin), oral gavage 4 weeks, construct subacute poisoning mouse model. This data proved was able induce an increased contents gastrointestinal hormones (CCK, GIP, GLP-1 PYY), neurotransmitters (5-HT SP), as well pro-inflammatory cytokines (IL-1β, IL-6 TNF-α) serum mice. disturbed composition microbiota, especially, Faecalibaculum Allobaculum, positively correlated with CCK, GLP-1, 5-HT, IL-1β, TNF-α, played certain role regulating host appetite. In conclusion, changes (especially increase abundance Allobaculum) promote upregulation hormones, neurotransmitters, cytokines, may be mechanism anorexia.

Language: Английский

Citations

4

Advanced Carriers for Precise Delivery and Therapeutic Mechanisms of Traditional Chinese Medicines: Integrating Spatial Multi‐Omics and Delivery Visualization DOI Open Access
Yusheng Zhang, Zhiguo Lü, Jing Guo

et al.

Advanced Healthcare Materials, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 19, 2025

Abstract The complex composition of traditional Chinese medicines (TCMs) has posed challenges for in‐depth study and global application, despite their abundance bioactive compounds that make them valuable resources disease treatment. To overcome these obstacles, it is essential to modernize TCMs by focusing on precise This involves elucidating the structure‐activity relationships within compositions, ensuring accurate in vivo delivery, monitoring delivery process. review discusses research progress precision treatment from three perspectives: spatial multi‐omics technology therapeutic activity, carrier systems medical imaging visualizing aim establish a novel paradigm advances therapy TCMs.

Language: Английский

Citations

0

Polymers for the treatment of Alzheimer’s disease DOI Creative Commons
Yunfeng Zhu,

Haibin Xu,

Canqing Yu

et al.

Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16

Published: Jan. 29, 2025

Alzheimer’s disease (AD) is one of the most common diseases central nervous system in middle-aged and elderly population. It a neurodegenerative disorder, its main clinical symptoms include loss established memories, decline learning capacity, buildup β-amyloid peptides. The often accompanied by changes formation neurofibrillary tangles. However, number drugs available for treatment AD remains limited. Currently, existing medications are not effective completely curing or stopping progression. Due to their excellent biocompatibility biodegradability, polymers have been widely used as drug delivery carriers various fields including cancer therapy wound healing. use enables targeted prolonged release profiles. In recent years, researchers made significant progress utilizing such polyethylene glycol, poly (lactic-co-glycolic acid) (PLGA), chitosan (CS) deliver blood-brain barrier receptor ligands AD. Moreover, many with inherent therapeutic properties developed, already marketed GV-971 well experimental PLGA CS oligosaccharide. This review summarizes applications over past few years highlights current limitations help better understand advancements polymer development identify future research directions.

Language: Английский

Citations

0

Nanoscale drug formulations for the treatment of Alzheimer's disease progression DOI Creative Commons

Liu Liqin,

Haini He,

Bert N. La Du

et al.

RSC Advances, Journal Year: 2025, Volume and Issue: 15(6), P. 4031 - 4078

Published: Jan. 1, 2025

Alzheimer's disease (AD) is a devastating neurodegenerative disorder with no effective disease-modifying treatments.

Language: Английский

Citations

0

The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases DOI Creative Commons
Lian Jin, L. S. Nie, Yan Deng

et al.

Cell Proliferation, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 11, 2025

ABSTRACT In spite of great advances in modern medicine, there are a few effective strategies for the treatment neurodegenerative diseases characterised by neuron loss or degeneration. This results from complex pathogenesis and limited drug uptake brain due to presence blood‐brain barrier. Nanoparticle‐based delivery systems expected improve utilisation. Polymeric nanoparticles represent promising carriers their unique advantages such as good biodegradability biocompatibility, flexibility surface modification nontoxicity. addition, genetic drugs may stop progression at level even avoid irreversible damage central nervous system. this review, an overview studies on polymer‐based system typical diseases, especially Alzheimer's Parkinson's is described. Meanwhile, applications gene these disorders discussed. And challenges future perspectives development polymeric concluded.

Language: Английский

Citations

0

The Chinese Herbal TiaoGanXiaoZhi Formula Alleviates the Progression of Metabolic‐Associated Fatty Liver Disease by Regulating the Gut Microbiota DOI Creative Commons
Wenying Qi, Xu Cao,

Yue Chen

et al.

Portal hypertension & cirrhosis, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 18, 2025

ABSTRACT Aims The TiaoGanXiaoZhi formula (TGXZ), a traditional Chinese medicine, has been shown to alleviate the progression of metabolic‐associated fatty liver disease (MAFLD) clinically. However, its underlying mechanism remains unclear. This study aimed investigate effects and mechanisms TGXZ in treating MAFLD mouse models. Methods model was established using high‐fat diet 5% fructose water over 16 weeks. At Week 8, mice exhibited significant steatosis, inflammation, insulin resistance. A total 42 were divided into normal feed (NFD) group ( n = 18) (HFD) 24). Six from each killed at 8 for serological histopathological assessments. remaining allocated NFD 6), HFD + Placebo 6) groups. (or placebo) administered clinical equivalent dose 7.699 g/(kg·d) respective groups, while groups received distilled water. Daily gavage started 9. 16, after fasting, body weight condition recorded, euthanized with pentobarbital sodium. Liver tissue collected further analysis, feces stored −80°C. Data graphed GraphPad Prism 8.0.0 analyzed SPSS Statistics 25.0. Results are expressed as mean ± standard deviation. Statistical comparisons made Student's t ‐test two one‐way ANOVA more than significance set p < 0.05. Compared group, treatment significantly downregulated white adipose (1.61 0.66 vs. 3.06 0.34 g, 0.0010), (1.22 0.16 1.98 0.39 0.0031), levels alanine aminotransferase (20.6 3.4 46.1 12.3 U/L, aspartate (99.9 19.1 168.4 34.3 0.0014), cholesterol (2.95 0.56 4.38 mmol/L, 0.0053), triglycerides (2.25 0.41 4.18 0.67 low‐density lipoprotein (0.66 0.11 1.41 0.52 0.0073), bile acid (0.71 2.18 0.61 0.0017), except high‐density (2.41 0.81 2.55 0.31 0.5655). transcriptome, fecal microbiota sequencing, lipidomics analysis demonstrated that improved expression genes related lipid metabolism, alleviated intestinal disorders, mitigated disturbances caused by MAFLD. Conclusions Our effectively inhibitory on may be attributed regulation gut microbiota, hepatic inflammation.

Language: Английский

Citations

0

Comparation of brain-targeting chitosan/sodium tripolyphosphate and ovalbumin/sodium carboxymethylcellulose nanoparticles on dihydromyricetin delivery and cognitive impairment in obesity-related Alzheimer's disease DOI
Zhiwei Li, Guodong Zheng, Changqing Fang

et al.

International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: 306, P. 141517 - 141517

Published: Feb. 26, 2025

Language: Английский

Citations

0

Rhynchophylline alleviates cognitive deficits in multiple transgenic mouse models of Alzheimer’s disease via modulating neuropathology and gut microbiota DOI
Mei Zhong,

Qingqing Xu,

Mingqing Huang

et al.

Acta Pharmacologica Sinica, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 26, 2025

Language: Английский

Citations

0

Plant polysaccharide‐capped nanoparticles: A sustainable approach to modulate gut microbiota and advance functional food applications DOI Creative Commons
Gafar Babatunde Bamigbade, Mohamed Abdin, Athira Jayasree Subhash

et al.

Comprehensive Reviews in Food Science and Food Safety, Journal Year: 2025, Volume and Issue: 24(2)

Published: March 1, 2025

Plant-derived polysaccharides have emerged as sustainable biopolymers for fabricating nanoparticles (polysaccharide-based nanomaterials [PS-NPs]), presenting unique opportunities to enhance food functionality and human health. PS-NPs exhibit exceptional biocompatibility, biodegradability, structural versatility, enabling their integration into functional foods positively influence gut microbiota. This review explores the mechanisms of interaction with microbiota, highlighting ability promote beneficial microbial populations, such Lactobacilli Bifidobacteria, stimulate production short-chain fatty acids. Key synthesis stabilization methods are discussed, focusing on role in improving bioavailability, stability, gastrointestinal delivery bioactive compounds systems. The potential address challenges science, including enhancing nutrient absorption, mitigating intestinal dysbiosis, supporting through innovative nanotechnology, is critically evaluated. Barriers enzymatic degradation physicochemical stability analyzed, alongside strategies optimize within complex matrices. systems offers a novel approach modulate improve health, drive development next-generation foods. Future research should focus bridging knowledge gaps metagenomic metabolomic profiling PS-NPs, optimizing design diverse applications, advancing health-promoting innovations.

Language: Английский

Citations

0